Nantahala Capital Management, LLC Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$1.2B

Holdings

120

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (120 positions)

#	Stock	Shares	Value	% Portfolio
101	TGTXTG THERAPEUTICS INC	150,000	$1.0M	0.09%
102	—NEOLEUKIN THERAPEUTICS INC	299,999	$1.0M	0.09%
103	DERMJOURNEY MED CORP	348,663	$955K	0.08%
104	TBBKBANCORP INC DEL	24,896	$859K	0.07%
105	SGRPSPAR GROUP INC	879,189	$847K	0.07%
106	—ACER THERAPEUTICS INC	918,349	$748K	0.06%
107	SRTSSENSUS HEALTHCARE INC	185,048	$513K	0.04%
108	APSGBPAPTOSE BIOSCIENCES INC	136,483	$382K	0.03%
109	LADRLADDER CAP CORP	27,073	$278K	0.02%
110	XGNEXAGEN INC	106,769	$258K	0.02%
111	ELTXELICIO THERAPEUTICS INC	30,000	$254K	0.02%
112	ADCTADC THERAPEUTICS SA	257,162	$231K	0.02%
113	TACTTRANSACT TECHNOLOGIES INC	31,108	$200K	0.02%
114	LUCDLUCID DIAGNOSTICS INC	158,135	$185K	0.02%
115	—BM TECHNOLOGIES INC	79,212	$158K	0.01%
116	RFLRAFAEL HLDGS INC	72,678	$138K	0.01%
117	DMPIEURKINTARA THERAPEUTICS INC	22,619	$91K	0.01%
118	GAIAGAIA INC NEW	23,144	$63K	0.01%
119	CUECUE BIOPHARMA INC	26,760	$62K	0.01%
120	—NOGIN INC	56,425	$30K	0.00%

PreviousPage 2 of 2